150 related articles for article (PubMed ID: 24382844)
1. Why should medical editors CARE about case reports?
Barić H; Andrijašević L
Croat Med J; 2013 Dec; 54(6):507-9. PubMed ID: 24382844
[No Abstract] [Full Text] [Related]
2. Antimongoloid as a pejorative term.
Masukume G
Croat Med J; 2014 Feb; 55(1):77-8. PubMed ID: 24577832
[No Abstract] [Full Text] [Related]
3. A lethal course of hypertrophic cardiomyopathy in Noonan syndrome due to a novel germline mutation in the KRAS gene: case study.
Nosan G; Bertok S; Vesel S; Yntema HG; Paro-Panjan D
Croat Med J; 2013 Dec; 54(6):574-8. PubMed ID: 24382853
[TBL] [Abstract][Full Text] [Related]
4. Bilateral giant coronary aneurysms in a 40-year-old male with Noonan syndrome caused by a KRAS germline mutation.
Fujimoto N; Nakajima H; Sugiura E; Dohi K; Kanemitsu S; Yamada N; Aoki Y; Nakatani K; Shimpo H; Nobori T; Ito M
Int J Cardiol; 2014 May; 173(3):e63-6. PubMed ID: 24703799
[No Abstract] [Full Text] [Related]
5. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
[TBL] [Abstract][Full Text] [Related]
6. Noonan syndrome and systemic lupus erythematosus in a patient with a novel KRAS mutation.
Leventopoulos G; Denayer E; Makrythanasis P; Papapolychroniou C; Fryssira H
Clin Exp Rheumatol; 2010; 28(4):556-7. PubMed ID: 20810036
[TBL] [Abstract][Full Text] [Related]
7. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
[TBL] [Abstract][Full Text] [Related]
8. Prenatal detection of Noonan syndrome by mutation analysis of the PTPN11 and the KRAS genes.
Houweling AC; de Mooij YM; van der Burgt I; Yntema HG; Lachmeijer AM; Go AT
Prenat Diagn; 2010 Mar; 30(3):284-6. PubMed ID: 20112233
[No Abstract] [Full Text] [Related]
9. No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes.
Neri G; Allanson J; Kavamura MI
J Med Genet; 2008 Dec; 45(12):832. PubMed ID: 19047498
[No Abstract] [Full Text] [Related]
10. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
11. [RIT1: a novel gene associated with Noonan syndrome].
Arroyo-Carrera I; Solo de Zaldivar-Tristancho M; Martin-Fernandez R; Vera-Torres M; Gonzalez de Buitrago-Amigo JF; Botet-Rodriguez J
Rev Neurol; 2016 Oct; 63(8):358-362. PubMed ID: 27699752
[TBL] [Abstract][Full Text] [Related]
12. Succesful MEK-inhibition of severe hypertrophic cardiomyopathy in RIT1-related Noonan Syndrome.
Leegaard A; Gregersen PA; Nielsen TØ; Bjerre JV; Handrup MM
Eur J Med Genet; 2022 Nov; 65(11):104630. PubMed ID: 36184070
[TBL] [Abstract][Full Text] [Related]
13. Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.
Lo FS; Lin JL; Kuo MT; Chiu PC; Shu SG; Chao MC; Lee YJ; Lin SP
Eur J Pediatr; 2009 Aug; 168(8):919-23. PubMed ID: 18958496
[TBL] [Abstract][Full Text] [Related]
14. PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome.
Ko JM; Kim JM; Kim GH; Yoo HW
J Hum Genet; 2008; 53(11-12):999-1006. PubMed ID: 19020799
[TBL] [Abstract][Full Text] [Related]
15. KRAS gene mutations in Noonan syndrome familial cases cluster in the vicinity of the switch II region of the G-domain: report of another family with metopic craniosynostosis.
Brasil AS; Malaquias AC; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
Am J Med Genet A; 2012 May; 158A(5):1178-84. PubMed ID: 22488932
[TBL] [Abstract][Full Text] [Related]
16. A severe clinical phenotype of Noonan syndrome with neonatal hypertrophic cardiomyopathy in the second case worldwide with RAF1 S259Y neomutation.
Jaouadi H; Chehida AB; Kraoua L; Etchevers HC; Argiro L; Kasdallah N; Blibech S; Delague V; Lévy N; Tebib N; Mrad R; Abdelhak S; Benkhalifa R; Zaffran S
Genet Res (Camb); 2019 Apr; 101():e6. PubMed ID: 31030682
[TBL] [Abstract][Full Text] [Related]
17. Expanding the genetic spectrum of Noonan syndrome.
Noordam K
Horm Res; 2007; 68 Suppl 5():24-7. PubMed ID: 18174700
[TBL] [Abstract][Full Text] [Related]
18. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
[TBL] [Abstract][Full Text] [Related]
19. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
20. Mek Inhibitor Reverses Hypertrophic Cardiomyopathy in RIT1 Mutated Noonan Syndrome: For the first time, hypertrophic cardiomyopathy was reversed in Noonan syndrome associated with a RIT1 mutation.
Am J Med Genet A; 2019 Aug; 179(8):1408-1409. PubMed ID: 31355539
[No Abstract] [Full Text] [Related]
[Next] [New Search]